Research progress of plant-derived natural products in thyroid carcinoma

Thyroid carcinoma (TC) is a prevalent malignancy of the endocrine system, with a notable rise in its detection rate in recent decades. The primary therapeutic approaches for TC now encompass thyroidectomy and radioactive iodine therapy, yielding favorable prognoses for the majority of patients. TC s...

Full description

Bibliographic Details
Main Authors: Qiujing Du, Weidong Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2023.1279384/full
_version_ 1797359890028560384
author Qiujing Du
Qiujing Du
Weidong Shen
author_facet Qiujing Du
Qiujing Du
Weidong Shen
author_sort Qiujing Du
collection DOAJ
description Thyroid carcinoma (TC) is a prevalent malignancy of the endocrine system, with a notable rise in its detection rate in recent decades. The primary therapeutic approaches for TC now encompass thyroidectomy and radioactive iodine therapy, yielding favorable prognoses for the majority of patients. TC survivors may necessitate ongoing surveillance, remedial treatment, and thyroid hormone supplementation, while also enduring the adverse consequences of thyroid hormone fluctuations, surgical complications, or side effects linked to radioactive iodine administration, and encountering enduring physical, psychosocial, and economic hardships. In vitro and in vivo studies of natural products against TC are demonstrating the potential of these natural products as alternatives to the treatment of thyroid cancer. This therapy may offer greater convenience, affordability, and acceptability than traditional therapies. In the early screening of natural products, we mainly use a combination of database prediction and literature search. The pharmacological effects on TC of selected natural products (quercetin, genistein, apigenin, luteolin, chrysin, myricetin, resveratrol, curcumin and nobiletin), which hold promise for therapeutic applications in TC, are reviewed in detail in this article through most of the cell-level evidence, animal-level evidence, and a small amount of human-level evidence. In addition, this article explores possible issues, such as bioavailability, drug safety.
first_indexed 2024-03-08T15:30:19Z
format Article
id doaj.art-4789c154ec664771982e535d9adee4ed
institution Directory Open Access Journal
issn 2296-2646
language English
last_indexed 2024-03-08T15:30:19Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Chemistry
spelling doaj.art-4789c154ec664771982e535d9adee4ed2024-01-10T04:47:05ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462024-01-011110.3389/fchem.2023.12793841279384Research progress of plant-derived natural products in thyroid carcinomaQiujing Du0Qiujing Du1Weidong Shen2The Affiliated Jiangyin People’s Hospital of Nantong University, Jiangyin, ChinaThird Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaThe Affiliated Jiangyin People’s Hospital of Nantong University, Jiangyin, ChinaThyroid carcinoma (TC) is a prevalent malignancy of the endocrine system, with a notable rise in its detection rate in recent decades. The primary therapeutic approaches for TC now encompass thyroidectomy and radioactive iodine therapy, yielding favorable prognoses for the majority of patients. TC survivors may necessitate ongoing surveillance, remedial treatment, and thyroid hormone supplementation, while also enduring the adverse consequences of thyroid hormone fluctuations, surgical complications, or side effects linked to radioactive iodine administration, and encountering enduring physical, psychosocial, and economic hardships. In vitro and in vivo studies of natural products against TC are demonstrating the potential of these natural products as alternatives to the treatment of thyroid cancer. This therapy may offer greater convenience, affordability, and acceptability than traditional therapies. In the early screening of natural products, we mainly use a combination of database prediction and literature search. The pharmacological effects on TC of selected natural products (quercetin, genistein, apigenin, luteolin, chrysin, myricetin, resveratrol, curcumin and nobiletin), which hold promise for therapeutic applications in TC, are reviewed in detail in this article through most of the cell-level evidence, animal-level evidence, and a small amount of human-level evidence. In addition, this article explores possible issues, such as bioavailability, drug safety.https://www.frontiersin.org/articles/10.3389/fchem.2023.1279384/fullnatural productthyroid carcinomatreatment challengesthyroid carcinoma survivorsredifferentiationdrug resistance
spellingShingle Qiujing Du
Qiujing Du
Weidong Shen
Research progress of plant-derived natural products in thyroid carcinoma
Frontiers in Chemistry
natural product
thyroid carcinoma
treatment challenges
thyroid carcinoma survivors
redifferentiation
drug resistance
title Research progress of plant-derived natural products in thyroid carcinoma
title_full Research progress of plant-derived natural products in thyroid carcinoma
title_fullStr Research progress of plant-derived natural products in thyroid carcinoma
title_full_unstemmed Research progress of plant-derived natural products in thyroid carcinoma
title_short Research progress of plant-derived natural products in thyroid carcinoma
title_sort research progress of plant derived natural products in thyroid carcinoma
topic natural product
thyroid carcinoma
treatment challenges
thyroid carcinoma survivors
redifferentiation
drug resistance
url https://www.frontiersin.org/articles/10.3389/fchem.2023.1279384/full
work_keys_str_mv AT qiujingdu researchprogressofplantderivednaturalproductsinthyroidcarcinoma
AT qiujingdu researchprogressofplantderivednaturalproductsinthyroidcarcinoma
AT weidongshen researchprogressofplantderivednaturalproductsinthyroidcarcinoma